Case Report: Chronic myeloid leukemia masquerading as essential thrombocythemia in a child: the imperative for early BCR::ABL1 testing in isolated thrombocytosis - Scorecard - MDSpire
Advertisement
Pediatric Case Study: Chronic Myeloid Leukemia Presenting as Isolated Thrombocytosis, Highlighting the Need for Early BCR::ABL1 Assessment in Differential Diagnosis
Clinical Scorecard: Pediatric Case Study: Chronic Myeloid Leukemia Presenting as Isolated Thrombocytosis, Highlighting the Need for Early BCR::ABL1 Assessment in Differential Diagnosis
At a Glance
Category
Detail
Condition
Chronic Myeloid Leukemia (CML)
Key Mechanisms
Presence of BCR::ABL1 fusion gene
Target Population
Pediatric patients presenting with isolated thrombocytosis
Care Setting
Pediatric hematology
Key Highlights
CML can present solely as isolated thrombocytosis in children.
Initial misdiagnosis of essential thrombocythemia (ET) can occur.
Early BCR::ABL1 testing is crucial for accurate diagnosis.
Imatinib therapy can lead to a complete cytogenetic response.
Pediatric CML accounts for only 2%-3% of childhood leukemias.
Guideline-Based Recommendations
Diagnosis
Perform BCR::ABL1 fusion gene testing in pediatric patients with isolated thrombocytosis.
Management
Initiate imatinib therapy upon confirmation of CML diagnosis.
Monitoring & Follow-up
Regular monitoring of platelet counts and BCR::ABL1 levels.
Risks
Misdiagnosis leading to inappropriate treatment.
Patient & Prescribing Data
Pediatric patients with CML presenting as isolated thrombocytosis.
Imatinib dosage adjusted based on serial platelet monitoring.
Clinical Best Practices
Consider CML in differential diagnosis for pediatric patients with thrombocytosis.
Conduct thorough laboratory evaluations including bone marrow biopsy and genetic testing.
